Product Code: RP-ID-10216577 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10216577
Market Overview:
Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (N. America, L. America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico) 2022-2030
"The global in vitro diagnostics market is estimated to be valued at ~USD 70 billion in 2021 and is further projected to escalate at a CAGR of 5% over the period 2022-2030. As the global elderly population continues to increase, high-quality medical services are required. Diagnosis plays an important role because most clinical decisions are based on the results of diagnostic tests. They help provide personalized treatments and take medications specifically for patients. In addition, the number of patients with chronic and infectious diseases is increasing globally, mainly due to unhealthy lifestyles, air and water pollution, and genetic modification of pathogenic microorganisms, which is estimated to accelerate the growth.
It is estimated that molecular diagnostic technology will promote the growth of the global market, mainly due to a large number of chronic diseases such as cancer, genetic diseases and non-invasive prenatal testing. In addition, due to the ease of testing, cost-effectiveness, and accuracy of the test results obtained, the end-user growth rate of home test kits will be high.
Depending on the product type, reagents and kits will have a higher growth rate because they are consumed during the diagnosis process and must be replenished. It is also expected that the increased investment of leading IVD companies in the development and automation of IVD products will stimulate market growth during the forecast period according to the specificity of the disease.
REPORT SCOPE :
GLOBAL IN VITRO DIAGNOSTICS MARKET ( ACTUAL PERIOD: 2014-2021, FORECAST PERIOD: 2022- 2030):
In Vitro Diagnostics Market-Scale, Growth, Technology Forecast Analysis-Centralized and Point Care, Diabetes Care, Molecular Diagnosis, and Application Analysis of Organizational Diagnosis : End-user analysis of infectious diseases and non-communicable diseases: hospitals, laboratories, home testing, other product analysis: medical devices, reagents and kits, services
REGIONAL ANALYSIS :
NORTH AMERICA , LATIN AMERICA , ASIA PACIFIC, EUROPE , MIDDLE EAST , AFRICA ( VACTUAL PERIOD: 2014-2021, FORECAST PERIOD: 2022- 2030
Laboratory Problem Analysis Market Analysis by Size, Growth, Technology Forecast: Concentration and Management, Diabetes treatment, molecular diagnosis, tissue identification, application analysis: infectious diseases, non-communicable diseases, end-user analysis: hospital, laboratory, home testing, other medical product equipment analysis, reagents and kits, services
COUNTRY ANALYSIS :
USA, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico (ACTUAL PERIOD: 2014-2021, FORECAST PERIOD: 2022- 2030): Disability Diagnosis Market Research Institute: Size, Growth, Scenario Analysis Techniques : Nursing and Nursing, Diabetes, Molecular Diagnostics, Clinical Tissue Analysis: Infectious Diseases, End-User Non-Infectious Disease Analysis: Hospitals, Laboratories, Home Testing, Other Product Analysis - Medical Tools, Reagents and Kits, Services. "
Roche, Sysmex, Abbott, Danaher, Siemens Healthineers, Biomerieux, Becton-Dickinson, Thermofisher Scientific, Bio-Rad, Ortho clinical Diagnostics.
Related Reports
Proof of Quality & Reliability
